Mareková Mária, Lauková Andrea, Skaugen Morten, Nes Ingolf
Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Medical Faculty UPJS, Tr. SNP 1, 040 01 Kosice, Slovakia.
J Ind Microbiol Biotechnol. 2007 Aug;34(8):533-7. doi: 10.1007/s10295-007-0226-4.
The new bacteriocin, termed enterocin M, produced by Enterococcus faecium AL 41 showed a wide spectrum of inhibitory activity against the indicator organisms from different sources. It was purified by (NH4)2SO4 precipitation, cation-exchange chromatography and reverse phase chromatography (FPLC). The purified peptide was sequenced by N-terminal amino acid Edman degradation and a mass spectrometry analysis was performed. By combining the data obtained from amino acid sequence (39 N-terminal amino acid residues was determined) and the molecular weight (determined to be 4628 Da) it was concluded that the purified enterocin M is a new bacteriocin, which is very similar to enterocin P. However, its molecular weight is different from enterocin P (4701.25). Of the first 39 N-terminal residues of enterocin M, valine was found in position 20 and a lysine in position 35, while enterocin P has tryptophane residues in these positions.
粪肠球菌AL 41产生的一种新型细菌素,命名为肠球菌素M,对来自不同来源的指示菌表现出广泛的抑制活性。它通过硫酸铵沉淀、阳离子交换色谱和反相色谱(快速蛋白质液相色谱)进行纯化。纯化后的肽通过N端氨基酸埃德曼降解法进行测序,并进行了质谱分析。通过结合从氨基酸序列获得的数据(确定了39个N端氨基酸残基)和分子量(确定为4628 Da),得出结论,纯化后的肠球菌素M是一种新型细菌素,与肠球菌素P非常相似。然而,其分子量与肠球菌素P不同(4701.25)。在肠球菌素M的前39个N端残基中,第20位是缬氨酸,第35位是赖氨酸,而肠球菌素P在这些位置是色氨酸残基。